Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s)
Background: This article sets up the initial discussion of the evolution of biopharmaceutical innovation in China through the perspective of sectoral innovation system (SIS). Methods: Two data sources including archival documentary data and field interviews were used in this study. Archival document...
Saved in:
Main Authors: | Hao Hu (Author), Chao-Chen Chung (Author) |
---|---|
Format: | Book |
Published: |
Kerman University of Medical Sciences,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biopharmaceutical Innovation System and the Influence of Policies: The Case of Taiwan (2000-2008)
by: Chao Chen Chung
Published: (2013) -
Systemic delivery of biopharmaceuticals: Parenteral forever?
by: Ana Grenha
Published: (2012) -
Health trajectories across the work exit transition in the 1990s, 2000s, and 2010s: the role of working conditions and policy
by: Maaike van der Noordt, et al.
Published: (2023) -
Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators
by: Rezaie Rahim, et al.
Published: (2012) -
Pediatric Biopharmaceutical Classification Systems (pBCS)
by: Justyna Srebro, et al.
Published: (2023)